Search Results - "Haskins, M. E."

Refine Results
  1. 1

    A model of mucopolysaccharidosis IIIB (Sanfilippo syndrome type IIIB): N‐acetyl‐α‐D‐glucosaminidase deficiency in Schipperke dogs by Ellinwood, N. M., Wang, P., Skeen, T., Sharp, N. J. H., Cesta, M., Decker, S., Edwards, N. J., Bublot, I., Thompson, J. N., Bush, W., Hardam, E., Haskins, M. E., Giger, U.

    Published in Journal of inherited metabolic disease (01-01-2003)
    “…Mucopolysaccharidosis III (MPS III) is characterized by lysosomal accumulation of the glycosaminoglycan (GAG) heparan sulphate (HS). In humans, the disease…”
    Get full text
    Journal Article
  2. 2

    Clinical characterization of cardiovascular abnormalities associated with feline mucopolysaccharidosis I and VI by Sleeper, M. M., Kusiak, C. M., Shofer, F. S., O’Donnell, P., Bryan, C., Ponder, K. P., Haskins, M. E.

    Published in Journal of inherited metabolic disease (01-06-2008)
    “…Summary Objective: The purpose of this study was to define the cardiovascular abnormalities present in young and adult cats affected with the lysosomal storage…”
    Get full text
    Journal Article
  3. 3

    Abnormal neuronal metabolism and storage in mucopolysaccharidosis type VI (Maroteaux-Lamy) disease by Walkley, S. U., Thrall, M. A., Haskins, M. E., Mitchell, T. W., Wenger, D. A., Brown, D. E., Dial, S., Seim, H.

    Published in Neuropathology and applied neurobiology (01-10-2005)
    “…Mucopolysaccharidosis (MPS) type VI, also known as Maroteaux–Lamy disease, is an inherited disorder of glycosaminoglycan  catabolism  caused  by  deficient …”
    Get full text
    Journal Article
  4. 4

    Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII by Sleeper, M M, Fornasari, B, Ellinwood, N M, Weil, M A, Melniczek, J, O'Malley, T M, Sammarco, C D, Xu, L, Ponder, K P, Haskins, M E

    Published in Circulation (New York, N.Y.) (17-08-2004)
    “…Mucopolysaccharidosis VII (MPS VII) is a lysosomal storage disease caused by deficient beta-glucuronidase (GUSB) activity resulting in defective catabolism of…”
    Get full text
    Journal Article
  5. 5

    Mucopolysaccharidosis VII in a Cat Caused by 2 Adjacent Missense Mutations in the GUSB Gene by Wang, P., Sorenson, J., Strickland, S., Mingus, C., Haskins, M.E., Giger, U.

    Published in Journal of veterinary internal medicine (01-07-2015)
    “…Background Mucopolysaccharidoses (MPS) are common lysosomal storage disorders causing typically progressive skeletal and ocular abnormalities. Objectives To…”
    Get full text
    Journal Article
  6. 6

    Adeno-associated virus serotypes 9 and rh10 mediate strong neuronal transduction of the dog brain by Swain, G P, Prociuk, M, Bagel, J H, O'Donnell, P, Berger, K, Drobatz, K, Gurda, B L, Haskins, M E, Sands, M S, Vite, C H

    Published in Gene therapy (01-01-2014)
    “…Canine models have many advantages for evaluating therapy of human central nervous system (CNS) diseases. In contrast to nonhuman primate models, naturally…”
    Get full text
    Journal Article
  7. 7

    Enzyme Replacement Therapy in Feline Mucopolysaccharidosis I by Kakkis, E.D., Schuchman, E., He, X., Wan, Q., Kania, S., Wiemelt, S., Hasson, C.W., O'Malley, T., Weil, M.A., Aguirre, G.A., Brown, D.E., Haskins, M.E.

    Published in Molecular genetics and metabolism (01-03-2001)
    “…Enzyme replacement therapy (ERT) has long been considered an approach to treating lysosomal storage disorders caused by deficiency of lysosomal enzymes. ERT is…”
    Get full text
    Journal Article
  8. 8

    Inheritance, biochemical abnormalities, and clinical features of feline Mucolipidosis II: the first animal model of human I-cell disease by Mazrier, H, Van Hoeven, M, Wang, P, Knox, V.W, Aguirre, G.D, Holt, E, Wiemelt, S.P, Sleeper, M.M, Hubler, M, Haskins, M.E

    Published in The Journal of heredity (01-09-2003)
    “…Mucolipidosis II (ML II), also called I-cell disease, is a unique lysosomal storage disease caused by deficient activity of the enzyme…”
    Get full text
    Journal Article
  9. 9

    Autologous transplantation of retrovirally transduced bone marrow or neonatal blood cells into cats can lead to long-term engraftment in the absence of myeloablation by SIMONARO, C. M, HASKINS, M. E, ABKOWITZ, J. L, BROOKS, D. A, HOPWOOD, J. J, ZHANG, J, SCHUCHMAN, E. H

    Published in Gene therapy (1999)
    “…Autologous transplantation of retrovirally transduced bone marrow (BM) or neonatal blood cells was carried out on eight cats (ranging in age from 2 weeks to 12…”
    Get full text
    Journal Article
  10. 10

    Molecular Basis of Feline β-Glucuronidase Deficiency: An Animal Model of Mucopolysaccharidosis VII by Fyfe, John C., Kurzhals, Rebeccah L., Lassaline, Mary E., Henthorn, Paula S., Alur, Prasad R.K., Wang, Ping, Wolfe, John H., Giger, Urs, Haskins, Mark E., Patterson, Donald F., Sun, Huaichang, Jain, Sanjeev, Yuhki, Naoya

    Published in Genomics (San Diego, Calif.) (01-06-1999)
    “…A family of domestic cats was found that exhibited clinical and biochemical abnormalities consistent with mucopolysaccharidosis VII, an autosomal recessive…”
    Get full text
    Journal Article
  11. 11

    Cloning of the Canine β-Glucuronidase cDNA, Mutation Identification in Canine MPS VII, and Retroviral Vector-Mediated Correction of MPS VII Cells by Ray, Jharna, Bouvet, Alain, DeSanto, Christopher, Fyfe, John C., Xu, Danbin, Wolfe, John H., Aguirre, Gustavo D., Patterson, Donald F., Haskins, Mark E., Henthorn, Paula S.

    Published in Genomics (San Diego, Calif.) (01-03-1998)
    “…Mucopolysaccharidosis type VII (MPS VII) is an inherited disease resulting from deficient activity of the lysosomal acid hydrolase β-glucuronidase (GUSB) and…”
    Get full text
    Journal Article
  12. 12

    MRI and electrophysiological abnormalities in a case of canine globoid cell leucodystrophy by Cozzi, F., Vite, C. H., Wenger, D. A., Victoria, T., Haskins, M. E.

    Published in Journal of small animal practice (01-08-1998)
    “…A six‐month‐old West Highland white terrier with progressive, multifocal neurological disease was diagnosed with canine globoid cell leucodystrophy (GCL)…”
    Get full text
    Journal Article
  13. 13

    Biochemical, pathological, and clinical response to transplantation of normal bone marrow cells into acid sphingomyelinase-deficient mice by MIRANDA, S. R. P, ERLICH, S, FRIEDRICH, V. L, HASKINS, M. E, GATT, S, SCHUCHMAN, E. H

    Published in Transplantation (15-04-1998)
    “…Acid sphingomyelinase knock-out (ASMKO) mice are a model of types A and B Niemann-Pick disease. In the present study, we evaluated whether bone marrow…”
    Get full text
    Journal Article
  14. 14

    Nurse leadership: Sustaining a culture of safety by Haskins, Helena E.M, Roets, Lizeth

    Published in Health SA = SA Gesondheid (2022)
    “…Background: Nurse leaders are essential to manage nursing practices that affect patient safety; therefore, they must create and sustain a sound safety culture…”
    Get full text
    Journal Article
  15. 15

    Inherited platelet delta-storage pool disease in dogs causing severe bleeding: an animal model for a specific ADP deficiency by Callan, M B, Bennett, J S, Phillips, D K, Haskins, M E, Hayden, J E, Anderson, J G, Giger, U

    Published in Thrombosis and haemostasis (01-09-1995)
    “…The nature of a disorder producing moderate to severe bleeding after minor trauma, venipuncture, and surgery was studied in 3 families of American cocker…”
    Get more information
    Journal Article
  16. 16

    Biochemical basis of the β-glucuronidase gene defect causing canine mucopolysaccharidosis VII by Ray, J, Scarpino, V, Laing, C, Haskins, ME

    Published in The Journal of heredity (01-01-1999)
    “…Mucopolysaccharidosis type VII (MPS VII), or Sly syndrome, is an autosomal recessive lysosomal storage disorder resulting from the deficiency in the activity…”
    Get full text
    Journal Article
  17. 17

    Retrovirus vector-mediated correction and cross-correction of lysosomal alpha-mannosidase deficiency in human and feline fibroblasts by Sun, H, Yang, M, Haskins, M E, Patterson, D F, Wolfe, J H

    Published in Human gene therapy (20-05-1999)
    “…Lysosomal alpha-mannosidase (EC 3.2.1.24) is an exoglycosidase in the glycoprotein degradation pathway. A deficiency of this enzyme causes the lysosomal…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20

    Neonatal Gene Transfer Leads to Widespread Correction of Pathology in a Murine Model of Lysosomal Storage Disease by Daly, Thomas M., Vogler, Carole, Levy, Beth, Haskins, Mark E., Sands, Mark S.

    “…For many inborn errors of metabolism, early treatment is critical to prevent long-term developmental sequelae. We have used a gene-therapy approach to…”
    Get full text
    Journal Article